Loading…

Medical Research Finder

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

Anti-PD-1 antibodies / PD-1 inhibitors + Chemotherapy (CT) & Nasopharyngeal carcinoma (NPC) / Nasopharynx cancer

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

Anti-PD-1 antibodies / PD-1 inhibitors + Chemotherapy (CT) work well for advanced Nasopharyngeal carcinoma (NPC) / Nasopharynx cancer. They are especially effective in first-line recurrent or metastatic cases. There is also some evidence they help beyond the first line.
Yeo et al. 2023 Oral Oncology 136: 106242
Yan et al. 2025 Tumori 111(1): 88-99

…

Efficacy and safety of PD-1 inhibitor plus chemotherapy in advanced nasopharyngeal carcinoma: A meta-analysis
Yan et al. 2025 Tumori 111(1): 88-99
Meta-Analysis
Efficacy of Anti-PD1 Blockade in Treating Recurrent or Metastatic Nasopharyngeal Cancer: A Systematic Review and Meta-analysis
Yeo et al. 2023 Oral Oncology 136: 106242
Meta-Analysis
Review

7/1/2026